Last reviewed · How we verify
Folic acid deficiency
Approved treatments
- Wellcovorin · Pfizer Japan Inc
- Fusilev · Spectrum Pharms
- Fusilev · Acrotech Biopharma
Fusilev works by bypassing the enzyme dihydrofolate reductase, allowing normal cell growth and DNA synthesis. - Folic Acid · Pfizer
Clinical guidelines
- FDA label — 1L
Leucovorin calcium is indicated in the treatment of megaloblastic anemias due to folic acid deficiency when oral therapy is not feasible. - FDA label — 1L
Leucovorin calcium is indicated in the treatment of megaloblastic anemias due to folic acid deficiency when oral therapy is not feasible.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Folic acid deficiency patent landscape — cliff calendar, originator estates, attackable patents
- Folic acid deficiency treatment landscape brief
- Folic acid deficiency treatment updates RSS
Frequently asked questions about Folic acid deficiency
What drugs treat Folic acid deficiency?
Tracked treatments include Wellcovorin, Fusilev, Folic Acid.
What is the treatment for Folic acid deficiency?
Standard treatment for Folic acid deficiency includes Wellcovorin, Fusilev, Folic Acid. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Folic acid deficiency?
FDA label publishes guidelines for Folic acid deficiency. 2 guideline references tracked.
Related
- Treatment landscape: Folic acid deficiency patent cliff · Folic acid deficiency CI report
- Treatment: Wellcovorin · Pfizer Japan Inc
- Treatment: Fusilev · Spectrum Pharms
- Treatment: Fusilev · Acrotech Biopharma
- Treatment: Folic Acid · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing